1. Main page
  2. Biotechnology
  3. Lung Therapeutics

Lung Therapeutics

5 Decision Makers · 5 Verified Contacts & Email Format

lungtx.com
📍 Austin, TXBiotechnology🗓 Est. 2013👥 11–50 employees

About Lung Therapeutics

Lung Therapeutics provides innovative treatments for underserved, life-threatening lung conditions.

Email Format

{first_name}{last_name}@lungtx.com — 100.0%

sarahsmith@lungtx.com

Leadership & Decision Makers

Contact details of 5 Lung Therapeutics decision makers

Matt Karpen

Vice President of CMC

  • Work email

    m********n@lungtx.com

Charles Garner

Chief Financial Officer

Andrew Mazar

Founder

Sharon Morriss

SVP, Clinical Development

Steven Idell

Founder

General Emails

General company emails, e.g. customer support lines

    info@lungtx.com

    General Inquiries

    careers@lungtx.com

    Unclassified inbox

    cgarner@lungtx.com

    Unclassified inbox

    nbspbwindsor@lungtx.com

    Unclassified inbox

    filn@lungtx.com

    Unclassified inbox

Verify Lung Therapeutics Emails

Similar Companies like Lung Therapeutics

Kite Pharma

kitepharma.com
Biotechnology · Los Angeles, CA · Est. 2009 · 101–250 employees

HQ: Los Angeles, CA

Adimab

adimab.com
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees

HQ: Lebanon, New Hampshire, United States

Loxo Oncology

loxooncology.com
Pharmaceuticals · New York, NY · Est. 2013 · 501–1000 employees

HQ: New York, NY

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Alexion Pharmaceuticals

alexion.com
Biotechnology · Cheshire, Connecticut, United States · Est. 1992 · 1001–5000 employees

HQ: Cheshire, Connecticut, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 27/07/2025

lungtx.com

737-802-1989

Austin, TX

Specialization: Therapeutics,
Legal Name: Lung Therapeutics Inc.
Business Type: Private
Employees: 11-50
Rounds: Series C
Founded Date: 2013
Company Type: For Profit
Operating Status: Active
Last Funding Type: Series C
Phone Number: 737-802-1989
Last Investment Activity: Nov 1, 2023
Investments Activity: Nov 1, 2023 Feb 2, 2023 Jul 13, 2021

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.